A phase I clinical trial assessing prophylactic infusion of donor CD45RA-negative memory - effector T cells into patients transplanted with hematopoietic stem cells from haploidentical donors after reduced intensity conditioning

This “allocated fund” from the Symphasis charitable umbrella foundation was awarded to Dr. Anne-Claire Mamez from the Geneva University Hospitals in April 2018 for four years.

News & Events

Posted on

Congratulations to Joëlle Ka Yann Ho, the winner of the ISREC Foundation’s 1st PF Leyvraz Award, promoting interprofessionalism in oncology.

 

Joëlle…

Read more
Posted on

Prof. Mikaël Pittet’s inaugural lecture will take place on Thursday, January 28, 2021 at 12.30 pm. His talk, entitled “Cancer immunotherapy: the next…

Read more
Posted on

The ISREC Foundation is proud to support Prof. Mikaël Pittet’s chair in immuno-oncology at the UNIGE. According to the “Web of Science” ranking, Prof.…

Read more
Posted on

The ISREC Foundation is honored to contribute to the research work in translational oncology performed in the laboratory of Prof. Curzio Rüegg at the…

Read more